HHGLIM M2 TAB 15.S

About

HHGLIM M2 Tablet is a fixed-dose combination medication used for the treatment of type 2 diabetes mellitus, containing Glimepiride 2mg and Metformin hydrochloride. Glimepiride is a sulfonylurea that primarily stimulates insulin secretion from pancreatic beta cells, thereby lowering blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues, leading to increased glucose uptake and utilization. The combination of these two agents provides a synergistic effect, addressing different aspects of glucose dysregulation in type 2 diabetes. This dual mechanism helps achieve better glycemic control than either drug alone, particularly in patients whose blood sugar is not adequately controlled by monotherapy with diet and exercise.

Uses

• Management of type 2 diabetes mellitus.
• To improve glycemic control in adults.
• When diet and exercise, plus monotherapy, are insufficient.
• To reduce fasting and postprandial blood glucose levels.

Directions For Use

Take one tablet orally once or twice daily with meals, as directed by your physician.

Benefits

• Provides comprehensive control of blood sugar.
• Effectively lowers both fasting and post-meal glucose.
• Improves insulin secretion and sensitivity.
• Reduces the risk of microvascular complications.
• Convenient single tablet combination therapy.
• Helps achieve target HbA1c levels.

Side Effects

• Hypoglycemia (low blood sugar)
• Nausea
• Diarrhea
• Abdominal pain
• Vomiting
• Headache
• Dizziness
• Metallic taste in mouth
• Skin rash
• Weight gain (with glimepiride)
• Lactic acidosis (rare, but serious with metformin)
• Anemia (rare)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption due to increased risk of hypoglycemia and lactic acidosis.
• Pregnancy - Not recommended during pregnancy; consult a doctor for alternative treatments.
• Breastfeeding - Not recommended during breastfeeding; consult a doctor for advice.
• Liver - Use with caution in patients with liver impairment; metformin is contraindicated in severe cases.
• Kidney - Contraindicated in severe renal impairment due to metformin accumulation and risk of lactic acidosis.
• Lung - Use with caution in severe lung conditions that may increase the risk of lactic acidosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.